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Abstract 
Background: Antimicrobial resistance in neonatal intensive care unit (NICU) patients is a threat, due to the frequent 
use of antimicrobial treatment and invasive devices in fragile babies. Since 2014 an active surveillance program of 
multidrug-resistant Gram-negative bacteria (MDR-GNB) carriage has been in place in the five NICUs of Palermo, Italy. 
In 2017 an increase in the prevalence of MDR-GNB, and in particular of extended-spectrum β-lactamases-producing 
Klebsiella pneumoniae (ESBL-KP), was observed in “Civico” hospital NICU.
Aim: To assess the impact of a coordinated intervention strategy in achieving long-lasting reduction of MDR-GNB 
prevalence in the NICU.
Methods: Rectal swabs were obtained monthly and processed to detect MDR-GNB using standard methods. MDR-
GNB were characterized by pulsed-field gel electrophoresis (PFGE). Since November 2017 the following intervention 
measures were applied: (a) two-months intensification of sample collection; (b) stakeholders meetings; (c) improve-
ment of prevention measures and antimicrobial policies.
Findings: During the intensified microbiological surveillance MDR-GNB and ESBL-KP were detected in rectal swabs 
(34.8%; 23.2%), nasal swabs (24.6%; 14.5%), oral swabs (14.5%; 5.4%), milk samples (32.1%; 17.9%), pacifiers swabs 
(30.8%; 17.9%) and from sub-intensive room surfaces. Thirteen ESBL-KP strains isolated from clinical and environmen-
tal samples showed identical PFGE patterns. The prevalence of MDR-GNB and ESBL-KP carriage significantly decreased 
in the year after intervention compared to the previous year (20.6% vs 62.2%; p < 0.001 and 11.1% vs 57.8%; p < 0.001). 
MDR-GNB were not detected at all for three months and ESBL-KP for five months. Multivariate analysis of the principal 
exposure variables showed that admission in the post-intervention period significantly reduced the risk of MDR-GNB 
carriage (adj-OR = 0.21, 95% CI = 0.076–0.629; p < 0.001).
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Introduction
The World Health Organization has declared antimicro-
bial resistance as one of the most dangerous public health 
threats of the last ten years with an increasing impact in 
the future [1].
Control and prevention of antimicrobial resistance and 
healthcare-related infections have been included in the 
Italian National Prevention Plan of Antimicrobial Resist-
ance 2017–2020.
Neonatal Intensive Care Units (NICUs) are complex 
assistive settings, heavily burdened by antimicrobial 
resistance, due to the widespread use of antimicrobial 
treatments in critically ill patients exposed to invasive 
devices and procedures. In these settings, prevention and 
control of infections and multi-drug resistance can play 
a crucial role in the outcome of critically ill newborns 
with otherwise limited therapeutic options [2, 3]. Adher-
ence by healthcare workers and parents to hand-washing 
protocols and other hygienic preventive measures in hos-
pitals, particularly in intensive care units, is considered 
essential to managing the spread of healthcare-associated 
infections. [4].
Surveillance is commonly defined as the on-going 
and systematic collection, analysis and interpretation of 
health data essential to the planning, implementation 
and evaluation in public health practices [5]. Nowadays, 
active surveillance of infections or carriage by multidrug 
resistant organisms (MDROs) may be recognized as an 
effective tool for the early detection of unusual patterns 
of microbial pathogens in a specific health-care setting 
[6–8] and can be used to define the local epidemiology of 
MDROs and the relative antimicrobial resistance map in 
individual NICUs [8–11].
Background
In accordance to internationally recognized prevention 
objectives [12], the University Hospital in Palermo, Italy, 
started an active surveillance program of MDRO carriage 
in the NICU in June 2009 [13–15]. In 2014 this program 
was extended to the other four NICUs in the metro-
politan area in order to define antimicrobial resistance 
patterns in different settings, and to monitor eventual 
microbial circulation related to patient movements inside 
the network of the local health system [16, 17].
The main focus of the program, which is still ongoing, 
is the epidemiological analysis of MDROs circulation, 
seasonal variability, associated risk factors, molecular 
typing of isolated bacteria and evaluation of antimicro-
bial resistance related to bacterial carriage. This active 
surveillance program involves an epidemiological team 
with its laboratory, a neonatal team, and NICU health-
care providers. Each stakeholder participates in regular 
meetings, in order to identify shared goals and methodol-
ogy and to provide periodic feedback of their activities. 
Collection of nasal and rectal swabs from each hospital-
ized newborn is performed every 4  weeks (for the pur-
poses of this study, each 4-week interval was defined as 
a month) in every NICU. Specimens are processed in 
order to identify carriage by MDROs. Complete figures 
and trends of microbial isolations are registered and peri-
odically reported to healthcare providers, together with 
the results of the in vitro antimicrobial sensitivity testing. 
The ultimate purpose is prevention and control of infec-
tious diseases through the early identification of new car-
riage clusters or changes in the time-line and pattern of 
colonization in a specific setting.
During the first four years of the program, we observed 
a higher prevalence of multi-drug resistant Gram-nega-
tive bacteria (MDR-GNB) carriage in the "Civico" hos-
pital NICU compared to the other NICUs in Palermo. 
A thorough examination of the annual prevalence of 
MDR-GNB carriage in rectal swabs in this health-care 
setting pinpointed a high percentage of MDR-GNB colo-
nized newborns in 2014 and an increasing trend in 2015 
(Table 1).
Based on this evidence, few additional episodic control 
measures were performed: an extraordinary collection 
of rectal swabs in November 2015 and a meeting with 
all health-care workers in January 2016 to inform them 
about the worrying colonization data and trends and to 
reinforce good clinical practices for infection control and 
prevention.
Despite an initial significant reduction of MDR-GNB 
carriage in 2016 (p < 0.001), the annual prevalence again 
showed an increase in 2017 (p < 0.001, Table  1), mainly 
Conclusions: MDR-GNB broadly circulate in NICU setting, they can colonize different body sites and spread through 
various vehicles. A coordinated strategy of multiple interventions with active cooperation between epidemiologists 
and clinicians in the NICU can effectively reduce their circulation and in particular the carriage of the most dangerous 
ESBL-KP strains.
Keywords: Antimicrobial resistance, Active surveillance program, Multi-drug resistant gram-negative bacteria, 
Intervention strategy, Extended spectrum β lactamases producing klebsiella pneumoniae, Neonatal intensive care 
unit
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involving Extended-spectrum β-lactamases-producing 
Klebsiella pneumoniae (ESBL-KP). This evidence led to 
the introduction in November 2017 of a more effective 
and long-lasting intervention to reinforce the implemen-
tation of the measures already adopted.
Aim of the study
The aim of this study was to quantify the impact of a 
coordinated intervention strategy in achieving a more 
effective and long-lasting reduction of MDR-GNB colo-
nization prevalence in “Civico” hospital NICU. This was 
done by comparing data from the “pre-intervention” 
period (from November 2016 to October 2017) with 
the “post-intervention” period (from November 2017 to 




The “Civico” hospital NICU is set in the adult hospital 
campus and includes two adjacent open spaces of 60 and 
40 square meters respectively. The NICU has 16 beds, of 
which 8 intensive and 8 sub-intensive. A hand-washing 
sink is located at each entrance. Around 370 term and 
preterm newborns are admitted annually.
Each area, intensive and sub-intensive, has two dedi-
cated neonatologists and two dedicated nurses, while 
another nurse is responsible for feeding-preparation.
All newborns included in our monthly surveillance 
program between November 2016 and October 2019 
were enrolled in this study. Rectal swabs for detection of 
MDR-GNB carriage were collected every 4  weeks from 
all newborns in the NICU, regardless of any clinical or 
laboratory signs of infection. Carriage was defined as a 
positive culture of MDR-GNB from at least one rectal 
swab collected during the NICU stay.
Since November 2017, a strategy of multiple coordi-
nated intervention measures was introduced to reduce 
the prevalence of MDR-GNB carriage.
Description of intervention measures
The intervention strategy included:
Intensification of sample collection
Microbiological surveillance was reinforced for 2 months 
(11/27/2017—01/23/2018) as follows:
• additional weekly samplings of rectal, nasal and oral 
mucosa swabs, swabs of devices and material in 
direct contact with each newborn (feeding bottles 
and pacifiers, and remnant milk after newborn feed-
ing) for the first month and every four weeks after-
wards;
• environmental samplings (room surfaces including 
milk preparation room, healthcare workers hands 
and stethoscopes) at the beginning of the interven-
tion and after two months. In February 2018 monthly 
sample collection reverted to the previous surveil-
lance with only rectal swabs.
Stakeholders weekly meetings
During the first two months of intervention, weekly 
meetings of NICU healthcare workers were held with 
experts from the surveillance team, sharing surveillance 
program results, pinpointing adherence of healthcare 
workers to standard precautions and discussing possible 
critical issues and preventive strategies. Subsequently, 
these meetings were scheduled monthly and involved 
only the NICU staff.
Improvement of prevention measures
The following changes in NICU organization and patient 
management were introduced:
• a new standard protocol for antimicrobial therapy 
was approved by the Hospital Health Management. 
The new guidelines standardized the timing for start-
ing and stopping therapy in suspected sepsis, the 
Table 1 Number and percentage of rectal samples positive for MDR-GNB, ESBL-producing GNB and ESBL-KP during four 
years surveillance in “Civico” Hospital NICU
a p < 0.05 with respect to 2014
b p < 0.05 with respect to 2015
c p < 0.05 with respect to 2016
period of surveillance 2014 (Feb—Dec) 2015 (Jan–Dec) 2016 (Jan–Dec) 2017 (Jan–Oct)
tested samples, n 180 184 164 160
MDR-GNB, n (%) 97 (53.9) 126 (68.5)a 71 (43.3)a,b 112 (70.0)a,c
ESBL, n (%) 92 (51.1) 102 (55.4) 61 (37.2)a,b 104 (65.0)a,c
ESBL-KP, n (%) 91(50.6) 43 (23.4)a 40 (24.4)a 104 (65.0)a,b,c
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duration of therapy in confirmed infections and sep-
sis, and the stopping of therapy after the first negative 
culture [18];
• hand-washing sensitization posters for caregivers 
and parents were placed in all rooms;
• contaminated devices were replaced with clean ones 
after feeding;
• introduction of bundles for common procedures, 
such as blood-sample collection, diaper change, milk 
preparation or fridge sanitation.
Evaluation of the impact of intervention measures
The prevalence of MDR-GNB, ESBL-producing GNB, 
ESBL-KP carriage was assessed and compared in two 
groups: newborns admitted in the pre-intervention 
period and newborns admitted in the post-intervention 
period.
In addition, in order to better evaluate the impact of 
the intervention measures and identify confounding 
factors that could impact MDR-GNB carriage, we con-
ducted a quasi-experimental study comparing the clinical 
features in two subgroups of patients: intervention popu-
lation and control population.
Inclusion criteria were admission in the NICU and 
enrollment in the surveillance program for MDR-GNB 
from November 2017 to March 2018 for the intervention 
population, and from November 2016 to March 2017 for 
the control population.
Exclusion criteria were:
• clinical records not available;
• outborn patients with MDR-GNB colonization in 
the first rectal swab (we do not perform rectal swab 
on NICU admission so we could not discriminate if 
MDR-GNB carriage was already present before the 
admission in the ward);
• patients with a positive rectal swab before the imple-
mentation of preventive measures (November 28th 
2017).
The outcome variable was detection of MDR-GNB 
in at least one rectal swab obtained for the surveillance 
program during the observation period of risk factors 
exposure.
The observational period was defined in colonized 
patients as the span of time between NICU admission 
and the date of the first positive rectal swab, and in non-
colonized patients as the span of time between NICU 
admission and the last rectal swab obtained.
We analysed the following clinical characteristics: 
type of delivery, sex, gestational age, birth weight, 
APGAR score at 5′, presence of malformations, feeding 
(breast milk and/or formulas), use of nasogastric tube, 
parenteral nutrition, use of invasive devices (central 
and peripheral venous access), invasive or non-invasive 
ventilation, surgical treatment, use of antimicrobials 
and hospital discharge (alive, dead or moved to another 
hospital).
Collection of samples and microbiological analysis
Collected samples were enriched in liquid cultures (Brain 
Heart Infusion, Oxoid) for 24 h at 37  °C, then plated in 
McConkey Agar with three antimicrobial discs (amoxi-
cillin-clavulanate 30  μg, meropenem 10  μg, ceftazidime 
30 μg) to detect multi-drug resistant bacteria [13]. After 
overnight incubation, suspected MDR colonies were iso-
lated for identification (standard biochemical methods), 
susceptibility testing and ESBL detection according with 
the European Committee on Antimicrobial Susceptibility 
Testing (EUCAST) guidelines [19–21].
MDR-GNB were defined as Gram-negative bacteria 
non-responders in vitro to at least three different classes 
of antimicrobials under testing (aminopenicillins, third-
generation cephalosporins, monobactams, aminoglyco-
sides and carbapenems).
Molecular characterization of MDR-GNB was per-
formed using pulsed-field gel electrophoresis (PFGE) 
after DNA-cutting with restriction enzymes and electro-
phoretic profiles were interpreted according to standard 
procedures [18, 22, 23].
Statistical analysis
Prevalence of MDR-GNB carriage, in relation to patient 
characteristics, procedures and clinical outcomes were 
compared using the chi-square test or Fisher test for 
categorical variables and Student’s t-test or the Mann–
Whitney U test for continuous variables.
A multivariate analysis by backward stepwise logistic 
regression was carried out to determine variables signifi-
cantly associated with MDR-GNB carriage. All variables 
that did differ between subjects with MDR-GNB carriage 
(p < 0.10) were initially entered in the model, and the least 
significant variables were removed one at a time. Good-
ness of fit of the logistic models was assessed using the 
Hosmer and Lemeshow test. Several multiple logistic 
regression models were tested in order to determine the 
most significant and simplest model with the best avail-
able fit for the data.
All significance tests were two-tailed, and p < 0.05 was 
considered significant.
Statistical analysis was carried out by using the R statis-
tical software package (version 3.6.1) and Microsoft Excel 
2010.
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Results
Intensified microbiological surveillance
During the intensified microbiological surveillance (per-
formed as described above from November 28 2017 
to January 23 2018) 69 rectal swabs, 69 nasal swabs, 55 
oral swabs, 39 samples from feeding bottles and pacifi-
ers and 28 milk samples were collected. MDR-GNB were 
detected from 24 rectal swabs (34.8%), 17 nasal swabs 
(24.6%), 8 swabs from oral mucosa (14.5%); moreover, 
9 milk samples (32.1%) and 12 pacifiers swabs (30.8%) 
were positive for MDR-GNB. ESBL-KP was detected 
from 16 rectal swabs (23.2%), 10 nasal swabs (14.5%), 3 
swabs from oral mucosa (5.4%); 5 milk samples (17.9%) 
and 7 pacifiers swabs (17.9%) were positive for ESBL-KP. 
The results indicate that MDR-GNB were significantly 
reduced during the post- intervention months and ESBL-
KP was not detected in the ward from January 23 to June 
2018. Temporal trends of MDR-GNB and ESBL-KP rectal 
carriage in relation to the intervention measures adopted 
are shown in Fig. 1.
Environmental testing yielded 104 samples: 45 NICU 
surface samples, 23 sub-intensive room surface samples, 
11 specimens from feeding-preparing surfaces, 15 from 
caregivers’ hands, 5 from stethoscopes, 5 from baby cots, 
2 from laminar-flow hoods. One powder and one liquid 
feeding formula sample were also analysed.
MDR-GNB isolates were detected in one sample from 
the sub-intensive room (ESBL-KP) on the first envi-
ronmental sampling day and in one sample from the 
feeding-preparing room (Stenotrophomonas maltophilia) 
on the second environmental sampling day. In the same 
data set, non-MDR Pseudomonas aeruginosa was iso-
lated in two samples from the sub-intensive and feed-
ing-preparing room. No MDR-GNB were isolated from 
healthcare workers hands.
Thirteen ESBL-KP strains isolated from rectal, nasal, 
oral swabs, milk, soothers and environmental surfaces 
were submitted to molecular characterization by PFGE. 
Analysis of electrophoretic profiles showed identical or 
closely related patterns suggesting a common origin for 
all tested strains (Fig. 2).
Comparison between pre‑ and post‑intervention periods
In the total study period (November 2016—October 
2019) 419 patients were enrolled in the surveillance, 142 
in the pre-intervention period (November 2016—Octo-
ber 2017), 143 and 134 respectively in the first and in the 
second year after the intervention (November 2017—
October 2019). A mean of 15 (SD = 2.76) patients were 
screened each month during the pre-intervention period. 
There was no significant difference in the post-interven-
tion period when 14.9 patients (SD = 2.61) were tested 
each month (p = 0.96).
A total of 539 rectal swabs were collected and ana-
lysed. In the pre-intervention period 180 rectal swabs 
were analysed: MDR-GNB were detected from 112/180 
(62.2%) rectal swabs and, in particular, 104/180 (57.8%) 
were ESBL-KP. In the first year of the post-intervention 
Fig. 1 Temporal trend of the prevalence of MDR-GNB rectal carriage and combined measures of infection control adopted. Column color 
shows the proportion of ESBL-KP positive samples (red) vs other MDR-GNB (blue). Green line represents the number of samples tested. 
AMS = antimicrobial stewardship; ES = environmental sampling; IC = infection control; MS = microbiological surveillance
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period 189 rectal swabs were analysed: MDR-GNB were 
detected from 39/189 (20.6%) rectal swabs and, in par-
ticular, 21/189 (11.1%) were ESBL-KP, while 2/189 (1.1%) 
were other ESBL-producing GNB. Carriage of ESBL-KP 
accounted for 92.8% (104/112) of all MDR-GNB isolated 
in the pre-intervention period and for 53.8% (21/39) of 
those isolated in the first year of the post-intervention 
period. Prevalence of MDR-GNB, ESBL-producing GNB 
and ESBL-KP carriage between the two periods was 
significantly different (p < 0.001). Chi square for trend 
was also significant (p < 0.001). In the second year of the 
post-intervention period (November 2018—October 
2019) 170 samples were analysed. Prevalence of MDR-
GNB carriage remained low (MDR-GNB 44/170, 25.9%; 
ESBL-producing GNB 15/170, 8.8%; ESBL-KP 6/170, 
3.5%). No significant differences were observed in the 
prevalence of MDR-GNB and ESBL-GNB with the previ-
ous year (p = 0.24 and p = 0.30, respectively). Prevalence 
of ESBL-KP was significantly lower in the second post-
intervention year (p = 0.006). Trends of MDR-GNB car-
riage in the pre- and post-intervention periods are shown 
in Fig. 3.
Quasi‑experimental study: comparison 
between intervention population and control population
One-hundred and two patients fulfilled the criteria to 
be included in the quasi-experimental study: 50 patients 
admitted from November 2017 to March 2018 (interven-
tion population) and 52 patients admitted from Novem-
ber 2016 to March 2017 (control population), according 
to the inclusion/exclusion algorithm (Fig. 4).
Characteristics of patients, medical devices and anti-
microbial treatment are summarized in Table 2.
Among the 102 patients, 54 (52.9%) were male, 15 
(15.5%) were twins, 76 (74.5%) were inborn. Caesar-
ean section was the most frequent type of delivery 
(65%), median gestational age was 34 weeks and 61.8% 
of babies were born preterm. Mean birth weight was 
2234 g and median APGAR score was 9. Eleven (10.8%) 
patients had some kind of malformations. Nine (8.9%) 
patients were admitted to the NICU more than 24  h 
after birth. Almost all newborns (99%) were given for-
mula complemented by breast milk in 73.5% of cases. 
Use of medical devices ranged between 18.6% for 
endotracheal tube and 79.4% for peripheral venous 
catheter. Three (2.9%) patients had surgery during their 
hospitalization. Antimicrobial therapy was adminis-
tered in 48% of patients. Amikacin (31.4%) and ampi-
cillin (23.5%) were the most frequently used drugs. 
MDR-GNB carriage affected 28 patients (27.4%). In 
particular, all ESBL-producing GNB were ESBL-KP (23 
patients, 22.5%). Enterobacter spp. and Escherichia coli 
carriage accounted for 3.9% and 1% of patients respec-
tively. Infection was diagnosed in 28 patients (27.7%) 
and 1 (1%) patient died. Mean duration of stay was 
24 days.
Distribution of some characteristics was significantly 
different between control and intervention population 
(Table  2). In particular, the proportion of inborn, pre-
term infants and breast milk feeding was significantly 
higher in the control population (p = 0.004, p = 0.02 
and p = 0.03 respectively), while birth weight was sig-
nificantly lower (p = 0.002). Mean duration of hospi-
tal stay markedly decreased from 28.4  days (SD 17.3) 
in the control population to 20  days (SD 19.4) in the 
Fig. 2 PFGE profile of 13 ESBL-KP strains isolated from rectal swab 
[1–4, 6–10], oral swab [3–7], nasal swab [13], soothers [2–5, 8, 9], 
milk [11], belonging to 5 patients and one environmental sample 
obtained from the changing table of the intermediate care room [12]. 
Samples 2 to 13 show identical pulsotype. Sample 1 differs by the 
presence of one band of about 350 Kb (arrow)
Fig. 3 MDR-GNB carriages in 539 rectal swabs collected in the 
pre- and post-intervention periods showing a significative and 
persistent decrease in prevalence of all MDR-GNB positives, and in 
particular of ESBL-KP positive (p < 0.001 between pre-intervention 
and  1st year post-intervention; p = 0.006 between 1st and 2nd year 
post-intervention)
Page 7 of 12Saporito et al. Antimicrob Resist Infect Control           (2021) 10:30  
intervention population (p = 0.02). In the interven-
tion population ampicillin-sulbactam was replaced by 
ampicillin.
Prevalence of MDR-GNB carriage was significantly 
lower in the intervention population compared with con-
trols (12% vs. 42.3%, p < 0.001), namely ESBL-KP positiv-
ity on rectal swabs showed a significant reduction (2% vs. 
42.3%, p < 0.001).
Multivariate analysis showed that the intervention 
population had a significantly reduced risk of MDR-
GNB carriage compared to the control population (adj-
OR = 0.21, 95% CI 0.076–0.629; p = 0.0047), whereas 
breast milk feeding was associated with an increased risk 
of MDR-GNB carriage (adj-OR = 11.9, 95% CI = 1.49–
95.9; p value = 0.019) (Table 3).
Discussion
After the evidence of a high MDR-GNB carriage in 
“Civico” NICU during the first two years of surveillance 
program, an episodic control strategy was implemented 
through an extraordinary sampling of patients and an 
informational meeting involving all healthcare workers of 
the ward in order to reinforce adherence to hand hygiene 
and good clinical practices. These measures resulted in a 
short-term decrease of MDR-GNB carriage prevalence 
from 68.5% in 2015 to 43.3% in 2016. However, after few 
months, the prevalence of MDR-GNB carriage increased 
again to reach 70% in 2017 (Table 1). A high prevalence of 
MDR-GNB carriage has also been reported from Ecuador 
(56%), Philippines (61%) and Hungary (> 50%) [24, 25]. 
Nevertheless, differences in local epidemiology, logistics 
and hospital organization must be considered. In our set-
ting, the contextual rapid increase in ESBL-KP carriage, 
that accounted for most MDR-GNB identified, suggested 
the need for a more structured and permanent inter-
vention to achieve long-lasting containment of carriage 
prevalence. This intervention strategy included the inten-
sification of sample collection with extraordinary clinical 
and environmental samples, frequent stakeholders meet-
ings and an improvement in prevention measures such as 
protocols for the correct use of antibiotic therapy, sensiti-
zation to hand-washing, implementation of checklists for 
common and invasive procedure management.
The impact of this multiple and coordinated interven-
tion strategy for the reduction of MDR-GNB carriage 
was statistically significant and sustained (especially in 
regard to ESBL-KP) even in the second year after inter-
vention, with a further reduction of ESBL-KP prevalence 
despite a modest increase of MDR-GNB carriage (Fig. 3). 
It should be noted that, since the beginning of the sur-
veillance program, rectal samples were collected every 
4 weeks from all newborns in the NICU, regardless of any 
clinical or laboratory signs of infection; therefore, previ-
ously colonized patients were sampled again if still pre-
sent in the NICU 4 weeks later. The number of patients 
and samples tested was similar in the pre-intervention 
Fig. 4 Algorithm for selection of intervention population and control population. RS = rectal swab
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period and in the first and second year after the inter-
vention and the mean number of samples collected from 
each patient was 1.3, both in the pre-intervention and in 
the post-intervention period. Thus, we are confident that 
the higher rate of MDR-GNB carriage in the pre-inter-
vention period is not the result of repeated sampling of a 
cohort of colonized babies.
The two months intensified surveillance of patients 
together with microbiological analysis of surfaces and 
healthcare workers’ hands was useful for strictly moni-
toring carriage trends, tracing transmission roots and 
enhancing the adherence to preventive measures, most 
importantly hand hygiene in the “five key moments” as 
suggested by WHO [26–28]. During this period, MDR-
GNB were detected not only from rectal swabs, but also 
from nasal and oral mucosa swabs. In addition, feed-
ing bottles, pacifiers and milk samples were analysed 
because, when contaminated during feeding, they can 
represent an additional source of MDR-GNB environ-
mental spreading. The role of cross-transmission of 
MDR-GNB was confirmed by the presence of identi-
cal or closely-related ESBL-KP strains in rectal, oral, 
nasal swabs, milk and environmental samples (Fig.  2). 
The evidence of MDR-GNB spread by saliva and milk 
Table 2 Comparison between  different variables in  intervention population and  control population in  quasi-
experimental study population
Statistically significant values (p < 0.05) are reported in bold characters






Male gender, n (%) 54 (52.9%) 29 (58%) 25 (48.1%) 0.31
Twin birth, n (%) 15 (15.5%) 6 (12.5%) 9 (18.4%) 0.42
Inborn, n (%) 76 (74.5%) 31 (62%) 45 (86.5%) 0.004
Admission to NICU > 24 h after birth, n (%) 9 (8.9%) 7 (14%) 2 (3.9%) 0.09
Birth through caesarean section, n (%) 65 (65%) 30 (60%) 35 (70%) 0.29
Gestational age, median (IQR), wks 34.5 (32-38) 36.5 (33-39) 33 (32-37) 0.014
Preterm birth (< 37wk), n (%) 63 (61.8%) 25 (50%) 38 (73.1%) 0.02
Birth weight, mean (SD), g 2234 (865) 2509 (844) 1980 (811) 0.002
Apgar score at 5 min, median (IQR) 9 (8-10) 9 (8-10) 9 (8-10) 0.71
Malformation, n (%) 11 (10.8%) 6 (12%) 5 (9.6%) 0.70
Nutrition and devices
Breast milk feeding, n (%) 75 (73.5%) 32 (64%) 43 (82.7%) 0.03
Formula feeding, n (%) 101 (99%) 49 (98%) 52 (100%) 0.49
Nasogastric tube, n (%) 43 (42.2%) 19 (38%) 24 (46.1%) 0.40
Parenteral nutrition, n (%) 60 (58.8%) 29 (58%) 31 (59.6%) 0.87
Central venous access device, n (%) 44 (43.1%) 20 (40%) 24 (46.1%) 0.53
Peripheral venous access device, n (%) 81 (79.4%) 37 (74%) 44 (84.6%) 0.18
Endotracheal tube, n (%) 19 (18.6%) 6 (12%) 13 (25%) 0.09
Noninvasive ventilation, n (%) 41 (40.2%) 22 (44%) 19 (36.5%) 0.44
Surgical procedure, n (%) 3 (2.9%) 2 (4%) 1 (1.9%) 0.61
Antimicrobial therapy
Antibiotics, any, n (%) 49 (48%) 21 (42%) 28 (53.8%) 0.23
Ampicillin, n (%) 24 (23.5%) 16 (32%) 8 (15.4%) 0.048
Ampicillin—Sulbactam, n (%) 11 (10.8%) 0 11 (21.1%)  < 0.001
Cephalosporines, n (%) 21 (20.6%) 7 (14%) 14 (26.9%) 0.11
Carbapenems, n (%) 18 (17.6%) 9 (18%) 9 (17.3%) 0.93
Amikacin, n (%) 32 (31.4%) 16 (32%) 16 (30.8%) 0.89
Glycopeptides, n (%) 17 (16.7%) 8 (16%) 9 (17.3%) 0.86
Metronidazole, n (%) 8 (7.8%) 5 (10%) 3 (5.8%) 0.48
Fluconazole, n (%) 20 (19.6%) 6 (12%) 14 (26.9%) 0.06
Rectal swab colonization
MDR-GNB, n (%) 28 (27.4%) 6 (12%) 22 (42.3%)  < 0,001
ESBL, n (%), all ESBL-KP 23 (22.5%) 1 (2%) 22 (42.3%)  < 0,001
Page 9 of 12Saporito et al. Antimicrob Resist Infect Control           (2021) 10:30  
increased the awareness of physicians and nurses and the 
adherence to hand hygiene before and after milk admin-
istration and led to the immediate substitution of con-
taminated devices after feeding [29]. In our experience, 
the finding of environmental contamination by intestinal 
bacteria highlighted the vital role of healthcare workers 
in the prevention of such spreading and prompted the 
implementation of a detailed procedure for diaper change 
and a better compliance to correct actions. Environmen-
tal contamination by ESBL-KP in the NICU has been 
reported by Szél and colleagues and was associated with 
high prevalence of MDR-GNB carriage and infection 
[24]. Successful elimination of ESBL-producing nosoco-
mial bacteria was accomplished with the implementation 
of a multidisciplinary intervention based on reduction of 
invasive procedures, changes of the antibiotic policies, 
microbiological screening at short intervals, progressive 
feeding, safer bathing protocol, staff hand hygiene train-
ing and continuous monitoring of the number of newly 
infected and newly colonized patients. This interdisci-
plinary approach aligns with ours for most of the meas-
ures taken and our results are comparable. In 2018 in 
Montpellier, a hospital surveillance program revealed an 
outbreak of ESBL-KP infection/colonization with incuba-
tors as the probable pathogen reservoir. ESBL-producing 
strains from 19 patients shared the same molecular pro-
file among themselves and with a strain isolated from an 
incubator after cleaning. In accordance with our findings, 
the introduction of new preventive hygiene measures 
stopped the outbreak, thus highlighting the fundamental 
role of environmental colonization management [30].
The role of MDR-GNB intestinal carriage as a risk fac-
tor for infection has been reported in several studies [29, 
31, 32]. For example, colonization by ESBL-producing 
GNB was a risk factor for developing ESBL infections 
in paediatric cardiac surgery patients [33]. Above all, 
the cross-transmission of colonization, is a sign of poor 
adherence to infection prevention measures, therefore 
the prevalence of colonization could be used as an indi-
cator of health workers’ compliance with standard and 
contact precautions in patient care. Furthermore, car-
riage certainly represents a potential source of dissemina-
tion of microorganisms from colonized patients to other 
NICUs or other paediatric and community health facili-
ties [34]. Recent studies have shown the persistence of 
MDR-GNB colonization even up to 2–5 years after NICU 
discharge, thus emphasizing the impact of the problem 
[35].
Our analysis considers the role of a whole set of con-
trol measures performed at the same time so that we are 
not able to identify the single contribution of each group 
of actions (intensification of sample collection, improve-
ment of prevention measures or stakeholders weekly 
meeting) on the reduction of MDR-GNB and ESBL-KP 
carriage. Different studies have analysed the impact of 
single measures on microbial colonization or infection. 
Table 3 Association between  MDR-GNB carriage and  multiple exposure variables in  quasi-experimental study 
population
* Hosmer–Lemeshow Goodness-of-Fit Test p value = 0.94
Exposure variable OR (95% CI) p Value Risk of MDR‑GNB carriage 
(adj‑OR – 95% CI)
Adj‑p*
Sex, ref. F 1.26 (0.52–3.10) 0.60
Admission in post-intervention period, ref. No 0.19 (0.06–0.51) 0.001 0.21 (0.076–0.629) 0.0047
Inborn, ref. No 6.1 (1.5–41.3) 0.02
Caesarean delivery, ref. No 1.9 (0.72–5.4) 0.19
Surgical intervention, ref. No 5.6 (0.49–64.5) 0.18
Gestational age, per week increase 0.87 (0.77–0.98) 0.023
Birth weight, per 100 gr increase 0.98 (0.97–0.99) 0.027
Breast milk feeding, ref. No 14.4 (2.5–313.5) 0.001 11.9 (1.49–95.9) 0.019
Nasogastric tube, ref. No 2.82 (1.15–7.1) 0.02
Endotracheal tube, ref. No 1.7 (0.56–4.9) 0.31
Ampicillin, ref. No 0.45 (0.12–1.4) 0.18
Ampicillin-sulbactam, ref. No 3.7 (0.98–14.4) 0.07
Cephalosporins, ref. No 3.1 (1.1–8.8) 0.02
Carbapenems, ref. No 1.02 (0.3–3.13) 1
Glycopeptides, ref. No 1.12 (0.35–3.5) 1
Fluconazole, ref. No 2.7 (0.94–7.6) 0.051
Duration of hospital stay before colonization, per day 
increase
0.96 (0.92–0.99) 0.04
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The correct management of central venous access proved 
to be effective against related infections [36]. Antimicro-
bial stewardship for the correct use of antibiotics in term 
of doses, duration of therapy and administration route is 
a key point for prevention and control of drug-resistance 
[37–39]. In other studies appropriate audits of outcomes 
and feedback to stakeholders have been included among 
essential infection prevention strategies in the paediatric 
population [40]. Intensification of microbiological sur-
veillance has been used as a strategy to contain ESBL-KP 
outbreaks [30].
The quasi-experimental analysis was carried out in 
order to determine if differences in the clinical charac-
teristics of patients could have had a confounding effect 
in the reduction of MDR-GNB carriage after introduc-
tion of coordinated intervention measures. Clearly 
defined selection criteria were used for both inter-
vention and control populations in order to minimize 
selection bias. Possible confounders related to different 
structural, organizational and seasonal settings were 
ruled out by choosing as controls a group of patients 
admitted in the same hospital ward in the same season 
of the preceding year and cared for by the same health-
care personnel. Prevalence of MDR-GNB and ESBL-KP 
carriage was significantly reduced in the intervention 
population compared to controls (12% vs 42.3% and 
2% vs 42.3%, respectively). The two populations were 
compared in respect to clinical features, use of medical 
devices (invasive and non-invasive) and type of treat-
ment; differences for specific variables were observed 
and statistically investigated (Table  2). Gestational age, 
birth weight, being inborn, type of feeding, antibiot-
ics and length of stay in NICU were variables associated 
to MDR-GNB carriage at univariate analysis and were 
included in the multivariate model in order to analyse 
their possible contribution to the global risk of coloniza-
tion. The risk of colonization by MDR-GNB in patients 
admitted during the intervention period was significantly 
decreased nearly fifth fold compared to that observed in 
the patients admitted during the control period. In addi-
tion, multivariate analysis confirmed the significant role 
of the introduction of coordinated intervention measures 
in reducing bacterial circulation, regardless of patient 
characteristics and procedures (Table 3).
Being inborn seemed to increase the risk of coloniza-
tion (OR = 1.90) even if this association was not signifi-
cant (0.55).
Cassettari et  al. observed a possible protective role of 
breastfeeding against ESBL-KP colonization in newborns 
[41], but our data did not support this evidence (adj-
OR = 11.9, p = 0.019), so the role of this factor needs to be 
further elucidated. The intrinsic protective role of human 
milk against infection is reported in several studies 
[42–44] but some authors have reported an increased 
risk of colonization in breast milk fed newborns in inten-
sive care settings [45, 46], which is in accord with our 
data. Possible biases in our population were related to 
the large amount of newborns fed with both maternal 
milk and formula. In addition, the handling and storage 
of expressed breast milk before administration should be 
further evaluated.
Previous studies reported the role of low gestational 
age and birth weight, mechanical ventilation, parenteral 
nutrition, invasive devices and antibiotics use as risk fac-
tors associated to MDR-GNB carriage [25, 34, 44, 46]. In 
our experience these associations were confirmed but 
were not significant, probably due to the small number 
of patients examined. The risk of colonization increased 
with lower gestational age and with the use of nasogastric 
tube (OR = 0.73, p = 0.09 and OR = 2.68, p = 0.22 respec-
tively). Moreover, lower birth weight was not significant 
probably because the mean weight in our population 
was high. First-line empiric antibiotic treatment was sig-
nificantly different between the two groups. In particular, 
ampicillin-sulbactam was replaced by ampicillin in the 
intervention period, as suggested by international guide-
lines [47]. Univariate analysis showed a significant asso-
ciation between the use of cephalosporins and the risk of 
MDR-GNB carriage (OR = 1.54, p = 0.02), however, this 
association was not confirmed by multivariate analysis 
(p = 0.68).
Our study did have some limitations. The complexity of 
the preventive intervention did not allow for evaluating 
the specific contribution of each measure implemented 
towards the reduction of MDR-GNB carriage. Some 
patients were excluded from the analysis because of the 
lack of clinical records; therefore we cannot know if their 
inclusion would have resulted in the identification of 
some other risk factors associated with MDR-GNB car-
riage. Moreover, we did not perform any screening on 
the mothers, so we could not rule out this likely source of 
colonization, as previously demonstrated by Danino et al. 
[48]. Finally, in our five-year active surveillance program 
(2014–2019)  the collection of rectal swabs was sched-
uled only every four weeks due to organizational needs, 
and included all the newborns in the NICU at the time 
of sample collection. As a consequence of this schedule, 
newborns hospitalized in the period between monthly 
samplings were not tested.
However, we believe that a network-based approach is 
essential for managing the circulation of multi-resistant 
pathogens, because as patients move between one hospi-
tal and another their microorganisms move together with 
them. This is particularly important for neonatal patients 
in an interconnected area, where they are frequently 
transferred from one NICU to another to undergo 
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specialized procedures [16, 37]. This approach also allows 
for the coordination of procedures with the aim of opti-
mizing assistance to the newborns [37]. With these goals, 
several neonatal networks have emerged in the world for 
the surveillance of care-related infections. The presence 
of an established surveillance program and of a work-
ing group allows for the identification of epidemiological 
changes in colonization trends and facilitates the imple-
mentation of effective control measures.
Conclusions
This study shows the impact of implementing a coor-
dinated strategy of control measures on MDR-GNB 
carriage in NICU patients and reveals its efficacy in 
obtaining a long-lasting reduction in the prevalence of 
MDR-GNB in an endemic setting.
The active surveillance program in the NICUs of the 
Palermo metropolitan area was useful in discovering the 
high-prevalence circulation of ESBL-KP in one NICU 
and to evaluate the efficacy of adopted measures. The 
implementation of preventive interventions proved to 
be effective, thanks to a cooperative and participatory 
approach between different professional profiles, all fac-
ing the problem of circulation and spread of antibiotic-
resistant bacteria.
Periodic meetings were essential for sharing surveil-
lance data, for increasing the awareness and relevance 
of the problem and for discussing critical points and 
possible solutions. Sharing of protocols, information 
and experiences within the NICU network of a metro-
politan area could be a additional and important area of 
improvement.
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